Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2016A030313010, 2018A030313506)
The Basic Research Project of Science and Innovation Commission of Shenzhen (JCYJ20160429185525629)
Natural Science Foundation of Shenzhen University General Hospital (0000040558)
Text and Data Mining valid from 2019-05-31
Received: 5 February 2019
Revised: 24 April 2019
Accepted: 10 May 2019
First Online: 31 May 2019
Ethics approval and consent to participate
: The study was authorized by the Institutional Review Board and Ethics Committee of the University of Hong Kong-Shenzhen Hospital. The enrolled patients in this study were provided with informed consent. The Institutional Review Board and Ethics Committee approved for the differentiation of PGCs from a human pluripotent stem cell. The teratoma experiments in our study were conformed to the national guidelines and were authorized by the institutional review board.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.